Zydus Lifesciences Ltd

Zydus Lifesciences, established in 1952 by Mr. Ramanbhai B. Patel with the initial name Cadila Healthcare Limited, is a distinguished player in the Indian drug discovery industry. The company offers a wide range of products, including active pharmaceutical ingredients, formulations, animal healthcare products, and wellness products. Zydus Lifesciences has made significant breakthroughs in the treatment of lung cancer, tuberculosis, cardiovascular diseases, and gastroenterology. In the fiscal year 2022, the company earned approximately INR 15,700 crores in revenue.

Zydus Lifesciences aspires to become a leading global healthcare provider with a unique approach. The company's mission is to create healthier communities by providing affordable and accessible medicines and solutions. The organization's values are centered on excellence, integrity, teamwork, innovation, and customer focus. The company's brand promise is to be dedicated to life in all its dimensions.

The company has been recognized for its excellence and innovation by various national and international awards. Moreover, the company is also committed to its social responsibility through its CSR program, Zydus Srishti. The program covers four areas: health (Swasthya), education (Shiksha), research (Shodh), and outreach (Saath). Through these initiatives, the company aims to make a positive difference in the lives of the underprivileged and marginalized sections of society.

Foundation: 1952
Headquarters: Ahmedabad, Gujarat

Website: https://www.zyduscadila.com/